Medicine & Research

The Next Chapter in MS Care

There is a tremendous amount of ongoing research, and strides are being made in the areas of diagnosis and management of this disease.

The Genetic Connection

While MS is linked to our genes, it is not defined by them. We believe that MS is partially genetic and partially caused by our surroundings.

15 Years of MS Therapy

The next decade will outpace the last in benefiting people with MS. That is not just a hope – progress is happening now.

The Potential Role of Chemokines in Remyelination

A family of proteins, known as chemokines, are important mediators of inflammation and lymphocyte trafficking into the brain.

Fampridine SR - One Step Closer to Reality

Very soon, a new drug will become available to help people with MS who suffer from muscle weakness and gait disturbances.

MS and Autoimmune Thyroiditis

It is good practice to check thyroid function as part of the diagnostic evaluation of anyone suspected of having MS.

Examining the Ampyra™ Experience

On Jan. 22, 2010 the FDA approved Ampyra (dalfampridine) as a treatment for walking impairment in MS.

LDN: Miracle or Myth?

LDN. You may have heard people raving about it, and you may have heard doctors shying away from it. So who is right?